CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the potential of HIV-specific antibodies to achieve long-term remission or cure for HIV. By studying individuals with durable HIV remission, the project aims to understand the immune mechanisms involved and develop effective clinical interventions for drug-free HIV management.
The search for a therapeutic intervention that can lead to HIV remission or cure is a global priority of the HIV field. HIV-specific antibodies have the potential to alter the clinical course of infection and enhance antiviral immune responses.
In addition, we have recently demonstrated that antibody-based HIV immunotherapy results in higher-than-average cases of durable HIV remission in the absence of antiretroviral medication.
Moreover, passive administration of HIV-specific antibodies was ass…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
